LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Assayed Controls Introduced for HIV and Hepatitis Testing

By LabMedica International staff writers
Posted on 23 Dec 2009
New assayed controls, which include analytes for human immunodeficiency virus (HIV) and hepatitis testing, have been launched.

The Assayed Virotrol I controls are prepared from human serum and are analyzed in the same manner as patient samples. The ready-to-use liquid formulation of the controls eliminates potential reconstitution variability. Routine use of Assayed Virotrol I controls provides laboratories with the ability to monitor the performance of their test procedures and assure quality on an ongoing basis. Values for many of the popular test systems are provided with each lot of Assayed Virotrol I.

Bio-Rad (Hercules, CA, USA) introduced the assayed Virotrol I controls for HIV and hepatitis testing. Assayed Virotrol I controls were designed for use as assayed external quality controls with in vitro diagnostic assays for the determination of antibodies to HIV-1, antibodies to Hepatitis B core Antigen (anti-HBc), antibodies to Hepatitis C Virus (anti-HCV), and Hepatitis B Surface Antigen (HBsAg).

Assessments and comparisons can be performed using Assayed Virotrol products with the Unity Interlaboratory Program. Unity Real Time, a quality control data management software solution designed to improve the effectiveness of quality control processes, is also available.

Related Links:

Bio-Rad


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group

Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
ADLM